Consequences of Perinatal Cannabis Exposure: Trends in Neurosciences


  • Monitoring marijuana use in the United States: challenges in an evolving environment.

    JAMA. 2016; 316: 1765-1766

  • Pharmacologic implications of marijuana use during pregnancy.

    Nurs. Womens Health. 2017; 21: 217-223

  • Marijuana use in pregnancy and lactation: a review of the evidence.

    Am. J. Obstet. Gynecol. 2015; 213: 761-778

  • Trends in self-reported and biochemically tested marijuana use among pregnant females in California from 2009-2016.

    JAMA. 2017; 318: 2490-2491

  • Prevalence and patterns of marijuana use among pregnant and nonpregnant women of reproductive age.

    Am. J. Obstet. Gynecol. 2015; 213: 201

  • Recommendations from cannabis dispensaries about first-trimester cannabis use.

    Obstet. Gynecol. 2018; 131: 1031-1038

  • Fetal disposition of delta 9-tetrahydrocannabinol (THC) during late pregnancy in the rhesus monkey.

    Toxicol. Appl. Pharmacol. 1987; 90: 315-321

  • Rodent models in neuroscience research: is it a rat race?.

    Dis. Model. Mech. 2016; 9: 1079-1087

  • Brain development in rodents and humans: identifying benchmarks of maturation and vulnerability to injury across species.

    Prog. Neurobiol. 2013; 106–107: 1-16

  • Modeling transformations of neurodevelopmental sequences across mammalian species.

    J. Neurosci. 2013; 33: 7368

  • Animal models of developmental brain injury: relevance to human disease. A summary of the panel discussion from the Third Hershey Conference on Developmental Cerebral Blood Flow and Metabolism.

    Dev. Neurosci. 2002; 24: 364-366

  • A translational model to determine rodent’s age from human foetal age.

    Sci. Rep. 2017; 7: 17248

  • Centers for Disease Control and Prevention. Breastfeeding among U.S. chidren born 2002–2014, CDC National Imunization Survey.

  • Transfer of inhaled cannabis into human breast milk.

    Obstet. Gynecol. 2018; 131: 783-788

  • Simultaneous analysis of frequently used licit and illicit psychoactive drugs in breast milk by liquid chromatography tandem mass spectrometry.

    J. Pharm. Biomed. Anal. 2011; 55: 309-316

  • Presence of Δ9-tetrahydrocannabinol in human milk.

    N. Engl. J. Med. 1982; 307: 819-820

    • Hensch T.K.
    • Bilimoria P.M.

    Re-opening windows: manipulating critical periods for brain development.

    Cerebrum. 2012; 2012: 11

  • Critical period regulation.

    Annu. Rev. Neurosci. 2004; 27: 549-579

  • Marijuana use by breastfeeding mothers and cannabinoid concentrations in breast milk.

    Pediatrics. 2018; 142e20181076

  • Early life programming and neurodevelopmental disorders.

    Biol. Psychiatry. 2010; 68: 314-319

  • Environmental epigenomics and disease susceptibility.

    Nat. Rev. Genet. 2007; 8: 253-262

    • Kundakovic M.
    • Champagne F.A.

    Early-life experience, epigenetics, and the developing brain.

    Neuropsychopharmacology. 2015; 40: 141-153

  • Prenatal cannabis exposure increases heroin seeking with allostatic changes in limbic enkephalin systems in adulthood.

    Biol. Psychiatry. 2007; 61: 554-563

  • Grey matter volume differences associated with extremely low levels of cannabis use in adolescence.

    J. Neurosci. 2019; 39: 1817-1827

    • Rodríguez de Fonseca F.
    • et al.

    Early changes in the development of dopaminergic neurotransmission after maternal exposure to cannabinoids.

    Pharmacol. Biochem. Behav. 1992; 41: 469-474

  • Maternal cannabis use alters ventral striatal dopamine D2 gene regulation in the offspring.

    Biol. Psychiatry. 2011; 70: 763-769

  • Cannabis use by women during pregnancy does not influence infant DNA methylation of the dopamine receptor DRD4.

    Am. J. Drug Alcohol Abuse. 2017; 43: 671-677

  • Cannabinoid exposure during pregnancy and its impact on immune function.

    Cell. Mol. Life Sci. 2019; 76: 729-743

  • Epigenetic regulation of immunological alterations following prenatal exposure to marijuana cannabinoids and its long term consequences in offspring.

    J. NeuroImmune Pharmacol. 2015; 10: 245-254

  • mu-Opioid receptor forms a functional heterodimer with cannabinoid CB1 receptor: electrophysiological and FRET assay analysis.

    J. Pharmacol. Sci. 2008; 108: 308-319

  • Cognitive impairment induced by delta9-tetrahydrocannabinol occurs through heteromers between cannabinoid CB1 and serotonin 5-HT2A receptors.

    PLoS Biol. 2015; 13e1002194

  • Ligand-induced regulation and localization of cannabinoid CB1 and dopamine D2L receptor heterodimers.

    J. Pharmacol. Exp. Ther. 2010; 332: 710-719

  • Endocannabinoid system and pregnancy.

    Reproduction. 2016; 152: R191-R200

  • The role of the endocannabinoid system in gametogenesis, implantation and early pregnancy.

    Hum. Reprod. Update. 2007; 13: 501-513

  • Multiple roles for the endocannabinoid system during the earliest stages of life: pre- and postnatal development.

    J. Neuroendocrinol. 2008; 20: 75-81

  • Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation.

    Prog. Lipid Res. 2013; 52: 633-650

  • The emerging functions of endocannabinoid signaling during CNS development.

    Trends Pharmacol. Sci. 2007; 28: 83-92

  • Endocannabinoid functions controlling neuronal specification during brain development.

    Mol. Cell. Endocrinol. 2008; 286: S84-S90

  • Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome.

    Eur. Arch. Psychiatry Clin. Neurosci. 2009; 259: 395-412

  • Differential developmental trajectories for CB1 cannabinoid receptor expression in limbic/associative and sensorimotor cortical areas.

    Synapse. 2011; 65: 278-286

  • CB1 cannabinoid receptor expression in the striatum: association with corticostriatal circuits and developmental regulation.

    Front. Pharmacol. 2012; 3: 21

  • Comparison of cannabinoid CB1 receptor binding in adolescent and adult rats: a positron emission tomography study using [F]MK-9470.

    Int. J. Mol. Imaging. 2011; 2011: 548123

  • Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells.

    PLoS One. 2007; 2e641

  • Cannabinoid receptor, CB1, expression follows neuronal differentiation in the early chick embryo.

    J. Anat. 2004; 205: 213-218

  • The endocannabinoid receptor, CB1, is required for normal axonal growth and fasciculation.

    Mol. Cell. Neurosci. 2008; 38: 89-97

  • Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period.

    Synapse. 1999; 33: 181-191

  • Preferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain.

    Neuroscience. 2003; 118: 681-694

  • Autoradiographic study of pre- and postnatal distribution of cannabinoid receptors in human brain.

    Neuroimage. 2001; 14: 1463-1468

  • Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning.

    Proc. Natl. Acad. Sci. U. S. A. 2008; 105: 8760-8765

  • Hardwiring the brain: endocannabinoids shape neuronal connectivity.

    Science. 2007; 316: 1212-1216

  • CB1 and CB2 cannabinoid receptor expression during development and in epileptogenic developmental pathologies.

    Neuroscience. 2010; 170: 28-41

  • Prenatal exposure to the CB1 and CB2 cannabinoid receptor agonist WIN 55,212-2 alters migration of early-born glutamatergic neurons and GABAergic interneurons in the rat cerebral cortex.

    J. Neurochem. 2014; 129: 637-648

  • Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain.

    Eur. J. Neurosci. 2003; 17: 1747-1754

  • Developmental trajectory of the endocannabinoid system in human dorsolateral prefrontal cortex.

    BMC Neurosci. 2012; 13: 87

  • Differential subcellular recruitment of monoacylglycerol lipase generates spatial specificity of 2-arachidonoyl glycerol signaling during axonal pathfinding.

    J. Neurosci. 2010; 30: 13992-14007

  • CB1 receptor-deficient mice as a model for depression.

    Neuroscience. 2012; 204: 193-206

  • Postpartum depression in rats: differences in swim test immobility, sucrose preference and nurturing behaviors.

    Behav. Brain Res. 2014; 272: 75-82

  • Diacylglycerol lipase-α and -β control neurite outgrowth in Neuro-2a cells through distinct molecular mechanisms.

    Mol. Pharmacol. 2011; 80: 60-67

  • Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor.

    Proc. Natl. Acad. Sci. U. S. A. 2005; 102: 19115-19120

  • Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain.

    J. Cell Biol. 2003; 163: 463-468

  • An introduction to the endogenous cannabinoid system.

    Biol. Psychiatry. 2016; 79: 516-525

  • Endocannabinoid signaling and synaptic function.

    Neuron. 2012; 76: 70-81

  • Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain.

    Future Neurol. 2011; 6: 459-480

  • Altering cannabinoid signaling during development disrupts neuronal activity.

    Proc. Natl. Acad. Sci. U. S. A. 2005; 102: 9388-9393

  • Marihuana use by pregnant women: neurobehavioral effects in neonates.

    Drug Alcohol Depend. 1980; 6: 415-424

  • Postnatal consequences of maternal marijuana use in humans.

    Ann. N. Y. Acad. Sci. 1989; 562: 123-132

  • 60- and 72-month follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol: cognitive and language assessment.

    J. Dev. Behav. Pediatr. 1992; 13: 383-391

  • 36- and 48-month neurobehavioral follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol.

    J. Dev. Behav. Pediatr. 1990; 11: 49-58

  • Visuoperceptual functioning differs in 9- to 12-year olds prenatally exposed to cigarettes and marihuana.

    Neurotoxicol. Teratol. 2000; 22: 11-20

  • A follow-up study of attentional behavior in 6-year-old children exposed prenatally to marihuana, cigarettes, and alcohol.

    Neurotoxicol. Teratol. 1992; 14: 299-311

  • Adolescents prenatally exposed to marijuana: examination of facets of complex behaviors and comparisons with the influence of in utero cigarettes.

    J. Clin. Pharmacol. 2002; 42: 97S-102S

  • Differential effects on cognitive functioning in 13- to 16-year-olds prenatally exposed to cigarettes and marihuana.

    Neurotoxicol. Teratol. 2003; 25: 427-436

  • The effects of prenatal tobacco and marijuana use on offspring growth from birth through 3 years of age.

    Neurotoxicol. Teratol. 1992; 14: 407-414

  • Effect of prenatal marijuana exposure on the cognitive development of offspring at age three.

    Neurotoxicol. Teratol. 1994; 16: 169-175

  • Effects of prenatal marijuana exposure on child behavior problems at age 10.

    Neurotoxicol. Teratol. 2000; 22: 325-336

  • Prenatal marijuana and alcohol exposure and academic achievement at age 10.

    Neurotoxicol. Teratol. 2004; 26: 521-532

  • Prenatal marijuana exposure and intelligence test performance at age 6.

    J. Am. Acad. Child Adolesc. Psychiatry. 2008; 47: 254-263

  • School achievement in 14-year-old youths prenatally exposed to marijuana.

    Neurotoxicol. Teratol. 2012; 34: 161-167

  • Demographic, emotional and social determinants of cannabis use in early pregnancy: the Generation R study.

    Drug Alcohol Depend. 2008; 98: 218-226

  • Growth, development and health from early fetal life until young adulthood: the Generation R Study.

    Paediatr. Perinat. Epidemiol. 2004; 18: 61-72

  • The Generation R study: design and cohort update 2010.

    Eur. J. Epidemiol. 2010; 25: 823-841

  • The Generation R study: design and cohort update 2017.

    Eur. J. Epidemiol. 2016; 31: 1243-1264

  • The Generation R study: biobank update 2015.

    Eur. J. Epidemiol. 2014; 29: 911-927

  • Conceptual issues in behavioral teratology and their application in determining long-term sequelae of prenatal marihuana exposure.

    J. Child Psychol. Psychiatry. 2002; 43: 81-102

  • A literature review of the consequences of prenatal marihuana exposure. An emerging theme of a deficiency in aspects of executive function.

    Neurotoxicol. Teratol. 2001; 23: 1-11

  • At the tip of an iceberg: prenatal marijuana and its possible relation to neuropsychiatric outcome in the offspring.

    Biol. Psychiatry. 2016; 79: e33-e45

  • Neuronal substrates and functional consequences of prenatal cannabis exposure.

    Eur. Child Adolesc. Psychiatry. 2014; 23: 931-941

  • Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes.

    Neurosci. Biobehav. Rev. 2015; 55: 119-146

  • Prenatal cannabis exposure and infant outcomes: overview of studies.

    Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2014; 52: 45-52

    • Huizink A.C.
    • Mulder E.J.H.

    Maternal smoking, drinking or cannabis use during pregnancy and neurobehavioral and cognitive functioning in human offspring.

    Neurosci. Biobehav. Rev. 2006; 30: 24-41

  • Altering endocannabinoid neurotransmission at critical developmental ages: impact on rodent emotionality and cognitive performance.

    Front. Behav. Neurosci. 2012; 6: 2

  • Prenatal alcohol, marijuana, and tobacco use: infant mental and motor development.

    Neurotoxicol. Teratol. 1995; 17: 479-487

  • Intrauterine cannabis exposure leads to more aggressive behavior and attention problems in 18-month-old girls.

    Drug Alcohol Depend. 2011; 118: 470-474

  • Prenatal substance exposure: effects on attention and impulsivity of 6-year-olds.

    Neurotoxicol. Teratol. 1999; 21: 109-118

  • Maternal and paternal cannabis use during pregnancy and the risk of psychotic-like experiences in the offspring.

    Schizophr. Res. 2018; 202: 322-327

  • Prenatal marijuana exposure: effect on child depressive symptoms at ten years of age.

    Neurotoxicol. Teratol. 2005; 27: 439-448

  • Predictors and correlates of high levels of depression and anxiety symptoms among children at age 10.

    J. Am. Acad. Child Adolesc. Psychiatry. 2006; 45: 223-230

  • Associations between polygenic risk for psychiatric disorders and substance involvement.

    Front. Genet. 2016; 7: 149

  • Genetic predisposition to schizophrenia associated with increased use of cannabis.

    Mol. Psychiatry. 2014; 19: 1201-1204

  • Prenatal marijuana exposure contributes to the prediction of marijuana use at age 14.

    Addiction. 2006; 101: 1313-1322

  • Effects of prenatal cigarette and marijuana exposure on drug use among offspring.

    Neurotoxicol. Teratol. 2005; 27: 267-277

  • Prenatal marijuana exposure predicts marijuana use in young adulthood.

    Neurotoxicol. Teratol. 2015; 47: 10-15

  • Effects of prenatal marijuana on response inhibition: an fMRI study of young adults.

    Neurotoxicol. Teratol. 2004; 26: 533-542

  • Perinatal Δ9-tetrahydrocannabinol exposure in rats modifies the responsiveness of midbrain dopaminergic neurons in adulthood to a variety of challenges with dopaminergic drugs.

    Drug Alcohol Depend. 1996; 42: 155-166

  • Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release.

    Proc. Natl. Acad. Sci. U. S. A. 2003; 100: 4915-4920

  • Inhaled delivery of Δ(9)-tetrahydrocannabinol (THC) to rats by e-cigarette vapor technology.

    Neuropharmacology. 2016; 109: 112-120

  • Methodological considerations in neurobehavioral teratology.

    Pharmacol. Biochem. Behav. 1996; 55: 455-457

  • Behavioural consequences of maternal exposure to natural cannabinoids in rats.

    Psychopharmacology. 1995; 122: 1-14

  • Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring.

    Cereb. Cortex. 2005; 15: 2013-2020

  • Perinatal exposure to delta-9-tetrahydrocannabinol causes enduring cognitive deficits associated with alteration of cortical gene expression and neurotransmission in rats.

    Addict. Biol. 2007; 12: 485-495

  • Prenatal tetrahydrocannabinol (THC) alters cognitive function and amphetamine response from weaning to adulthood in the rat.

    Neurotoxicol. Teratol. 2012; 34: 63-71

  • Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats.

    J. Psychopharmacol. (Oxford). 2006; 20: 611-621

  • Long-term effects on cortical glutamate release induced by prenatal exposure to the cannabinoid receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone: an in vivo microdialysis study in the awake rat.

    Neuroscience. 2004; 124: 367-375

  • Altered regulation of glutamate release and decreased functional activity and expression of GLT1 and GLAST glutamate transporters in the hippocampus of adolescent rats perinatally exposed to delta(9)-THC.

    Pharmacol. Res. 2010; 61: 334-341

  • Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 increases glutamate uptake through overexpression of GLT1 and EAAC1 glutamate transporter subtypes in rat frontal cerebral cortex.

    Neuropharmacology. 2007; 53: 369-378

  • Short- and long-term consequences of prenatal exposure to the cannabinoid agonist WIN55,212-2 on rat glutamate transmission and cognitive functions.

    J. Neural Transm. (Vienna). 2009; 116: 1017-1027

  • Miswiring the brain: Δ9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway.

    EMBO J. 2014; 33: 668-685

  • Molecular model of cannabis sensitivity in developing neuronal circuits.

    Trends Pharmacol. Sci. 2011; 32: 551-561

  • Frau, R. et al. Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone. Nat. Neurosci. (in press).

  • Scheyer, A.F. et al., Cannabinoid exposure via lactation in rats disrupts perinatal programming of the GABA trajectory and select early-life behaviors. Biol. Psychiatry Published online September 5, 2019.

  • Sex-dependent effects of in utero cannabinoid exposure on cortical function.

    Elife. 2018; 7e36234

  • Persistent inhibitory circuit defects and disrupted social behaviour following in utero exogenous cannabinoid exposure.

    Mol. Psychiatry. 2017; 22: 56-67

  • Maternal exposure to delta9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central mu opioid receptors in adult offspring female rats.

    Brain Res. 1998; 807: 101-109

  • Effects of perinatal exposure to delta 9-tetrahydrocannabinol on operant morphine-reinforced behavior.

    Pharmacol. Biochem. Behav. 2003; 75: 577-584

  • Role of cannabinoidergic mechanisms in ethanol self-administration and ethanol seeking in rat adult offspring following perinatal exposure to Delta9-tetrahydrocannabinol.

    Toxicol. Appl. Pharmacol. 2007; 223: 73-85

  • Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide.

    Nature. 1999; 400: 452-457

  • The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide.

    Mol. Pharmacol. 2005; 67: 15-19

  • A missense mutation in human fatty acid amide hydrolase associated with problem drug use.

    Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 8394-8399

  • FAAH genetic variation enhances fronto-amygdala function in mouse and human.

    Nat. Commun. 2015; 6: 6395

  • Endocannabinoids modulate cortical development by configuring Slit2/Robo1 signalling.

    Nat. Commun. 2014; 5: 4421

  • Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: evidence from an endocannabinoid system-level analysis.

    J. Abnorm. Psychol. 2015; 124: 860-877

  • The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors.

    Nat. Neurosci. 2010; 13: 951-957

  • Cannabis use during pregnancy: pharmacokinetics and effects on child development.

    Pharmacol. Ther. 2018; 182: 133-151

  • Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis.

    BMJ Open. 2016; 6e009986

  • Executive functioning in preschool-age children prenatally exposed to alcohol, cocaine, and marijuana.

    Alcohol. Clin. Exp. Res. 2003; 27: 647-656

  • Correlates and trends in youth co-use of marijuana and tobacco in the United States, 2005-2014.

    Drug Alcohol Depend. 2018; 185: 238-244

  • Probability and predictors of the cannabis gateway effect: a national study.

    Int. J. Drug Policy. 2015; 26: 135-142

  • Prenatal care reduces the impact of illicit drug use on perinatal outcomes.

    J. Perinatol. 2003; 23: 354-360

  • Perinatal marijuana use and the developing child.

    JAMA. 2018; 320: 545-546

  • Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies.

    Nat. Rev. Neurosci. 2014; 15: 786-801

  • Prenatal cannabis exposure – the “first hit” to the endocannabinoid system.

    Neurotoxicol. Teratol. 2016; 58: 5-14

  • Maternal exposure to low doses of delta9-tetrahydrocannabinol facilitates morphine-induced place conditioning in adult male offspring.

    Pharmacol. Biochem. Behav. 1998; 61: 229-238

  • Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents.

    Psychopharmacology. 2011; 214: 5-15

  • Interacting cannabinoid and opioid receptors in the nucleus accumbens core control adolescent social play.

    Front. Behav. Neurosci. 2016; 10: 211

  • μ Opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis.

    Br. J. Pharmacol. 2006; 148: 387-395

  • Prenatal exposure to tobacco and cannabis: effects on autonomic and emotion regulation.

    Neurotoxicol. Teratol. 2018; 68: 47-56

  • Schuetze, P. et al. Prenatal exposure to tobacco and marijuana and child autonomic regulation and reactivity: an analysis of indirect pathways via maternal psychopathology and parenting. Dev. Psychobiol. Published online March 13, 2019.

    • Subbaraman M.S.
    • Kerr W.C.

    Simultaneous versus concurrent use of alcohol and cannabis in the National Alcohol Survey.

    Alcohol. Clin. Exp. Res. 2015; 39: 872-879

  • Breit, K.R. et al. The effects of alcohol and cannabinoid exposure during the brain growth spurt on behavioral development in rats. Birth Defects Res. 111, 760–774.

  • Adverse outcome pathway of developmental neurotoxicity resulting from prenatal exposures to cannabis contaminated with organophosphate pesticide residues.

    Reprod. Toxicol. 2019; 85: 12-18

  • Bisphenol A induces hypothalamic down-regulation of the cannabinoid receptor 1 and anorexigenic effects in male mice.

    Pharmacol. Res. 2016; 113: 376-383

  • Synergistic effect between maternal infection and adolescent cannabinoid exposure on serotonin 5HT1A receptor binding in the hippocampus: testing the “two hit” hypothesis for the development of schizophrenia.

    ISRN Psychiatry. 2012; 2012: 451865

  • [ad_2]

    Latest posts